The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.
Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.
The English language version is always the official and authoritative version of this website.
NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.
Synopsis As Introduced Amends the State Employees Group Insurance Act of 1971. Requires the State Employees Group Insurance Program to provide coverage for all FDA-approved treatments or medications prescribed to slow the progression of Alzheimer's Disease or another related dementia, as determined by a physician licensed to practice medicine in all its branches. Provides that diagnostic testing necessary for a physician to determine the appropriate use of treatments or medications shall be covered by the State Employees Group Insurance Program.
Senate Committee Amendment No. 1 Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. In a provision regarding coverage for Alzheimer's Disease or other related dementia, limits the provision to beginning on July 1, 2025 (rather than January 1, 2025). Requires FDA-approved treatments or medications prescribed to slow the progression of Alzheimer's Disease or another related dementia to be medically necessary in order to qualify for coverage under the State Employees Group Insurance Program. Adds a specific prohibition on step therapy for treatment of Alzheimer's Disease or another related dementia.
This site is maintained for the Illinois General Assembly
by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706
Contact ILGA Webmaster